ESR1 and breast carcinoma: Higher CXCL12 protein expression indicated a better disease-free survival and overall survival in breast cancer patients, and had a positive relation with positive estrogen receptor (ER) status, negative human epidermal growth factor receptor (Her)-2 status, and small tumor size [17].